Dr. Kenneth J. Friedman, discusses the drug Rituximab for those with ME/CFS. How it acts to aid those with immune system disorders and the need for further study of this family of drugs.
Kenneth Friedman, Ph.D., is a member of the Board of Directors of the IACFS/ME, Associate Professor of Pharmacology and Physiology, New Jersey Medical School (retired) and a member of the Board of Advisors of cfsKnowledgeCenter.
For more information on ME/CFS, go to: cfsknowledgecenter.com.
For more information on the ME/CFS private social network, go to: me-cfscommunity.com.
Please Help Us Help You. Tax deductable donations in support of our work on behalf of those afflicted with ME/CFS, fibromyalgia and GWI may be made through PayPal at: paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=7561374